PURPOSE: To report on the acute and late gastrointestinal (GI) and genitourinary (GU) toxicity associated with a unique technique of image-guided radiotherapy (IGRT) in patients undergoing postprostatectomy irradiation. METHODS AND MATERIALS: Fifty patients were treated with intensity-modulated radiation therapy (IMRT) after radical prostatectomy. Daily image guidance was performed to localize the prostate bed using kilovoltage imaging or cone-beam computed tomography. The median prescription dose was 68 Gy (range, 62-68 Gy). Toxicity was graded every 3 to 6 months according to the Common Terminology Criteria for Adverse Events version 3.0. RESULTS: The median follow-up was 24 months (range, 13-38 months). Grade 2 acute GI and GU events occurred in 4 patients (8%) and 7 patients (14%), respectively. No Grade 3 or higher acute GI or GU toxicities were observed. Late Grade 2 GI and GU events occurred in 1 patient (2%) and 8 patients (16%), respectively. Only a single (2%) Grade 3 or higher late toxicity was observed. CONCLUSIONS: Image-guided IMRT in the postprostatectomy setting is associated with a low frequency of acute and late GI/GU toxicity. These results compare more favorably to radiotherapy techniques that do not use in-room image-guidance, suggesting that daily prostate bed localization may reduce the incidence of adverse events in patients undergoing postprostatectomy irradiation. 2010 Elsevier Inc. All rights reserved.
PURPOSE: To report on the acute and late gastrointestinal (GI) and genitourinary (GU) toxicity associated with a unique technique of image-guided radiotherapy (IGRT) in patients undergoing postprostatectomy irradiation. METHODS AND MATERIALS: Fifty patients were treated with intensity-modulated radiation therapy (IMRT) after radical prostatectomy. Daily image guidance was performed to localize the prostate bed using kilovoltage imaging or cone-beam computed tomography. The median prescription dose was 68 Gy (range, 62-68 Gy). Toxicity was graded every 3 to 6 months according to the Common Terminology Criteria for Adverse Events version 3.0. RESULTS: The median follow-up was 24 months (range, 13-38 months). Grade 2 acute GI and GU events occurred in 4 patients (8%) and 7 patients (14%), respectively. No Grade 3 or higher acute GI or GU toxicities were observed. Late Grade 2 GI and GU events occurred in 1 patient (2%) and 8 patients (16%), respectively. Only a single (2%) Grade 3 or higher late toxicity was observed. CONCLUSIONS: Image-guided IMRT in the postprostatectomy setting is associated with a low frequency of acute and late GI/GU toxicity. These results compare more favorably to radiotherapy techniques that do not use in-room image-guidance, suggesting that daily prostate bed localization may reduce the incidence of adverse events in patients undergoing postprostatectomy irradiation. 2010 Elsevier Inc. All rights reserved.
Authors: Murilo A Luz; Alan Dal Pra; Hin-Yu Vincent Tu; Marie Duclos; Fabio L B Cury; Bassel G Bachir; Armen G Aprikian; Simon Tanguay; Wassim Kassouf Journal: Can Urol Assoc J Date: 2013 Nov-Dec Impact factor: 1.862
Authors: Timothy N Showalter; Nitin Ohri; Kristopher G Teti; Kathleen A Foley; Scott W Keith; Edouard J Trabulsi; Costas D Lallas; Adam P Dicker; Jean Hoffman-Censits; Laura T Pizzi; Leonard G Gomella Journal: Int J Radiat Oncol Biol Phys Date: 2011-05-24 Impact factor: 7.038
Authors: Paolo Borghetti; Luigi Spiazzi; Claudia Cozzaglio; Sara Pedretti; Bruno Caraffini; Luca Triggiani; Diana Greco; Lilia Bardoscia; Fernando Barbera; Michela Buglione; Stefano Maria Magrini Journal: Radiol Med Date: 2017-09-18 Impact factor: 3.469
Authors: Raymond H Mak; Daniel Hunt; Jason A Efstathiou; Niall M Heney; Christopher U Jones; Himu R Lukka; Jean-Paul Bahary; Malti Patel; Alexander Balogh; Abdenour Nabid; Mark H Leibenhaut; Daniel A Hamstra; Kevin S Roof; Robert Jeffrey Lee; Elizabeth M Gore; Howard M Sandler; William U Shipley Journal: Urol Oncol Date: 2016-07-02 Impact factor: 3.498